The Canadian Antimicrobial Innovation Coalition (CAIC) is pleased to host a podcast series. Our AMR Action Podcast aims to elevate the diverse perspectives of individuals committed to the issue of antimicrobial resistance. We will discuss important topics through an innovation lens, and address solutions that can be suited to our Canadian health system. Please join us!
On this 15th episode of the AMR Action Podcast, Christopher Micetich, President and CEO of both Brass Dome Ventures Ltd. and Fedora Pharmaceuticals Inc., joins Dani Peters, CAIC Senior Advisor, to discuss the current state of antimicrobial innovation within the biotech industry and the challenges faced in developing new solutions. He shares some of the history of antimicrobial innovation in Alberta, including the discovery of Tazobactam by his late father and team of researchers, and suggests how Alberta can position itself as a leader in antimicrobial innovation on a global scale, leveraging the upcoming G7 summit hosted in the region.
In honour of World Antimicrobial Resistance (AMR) Awareness Week (WAAW) 2024, the AMR Action Podcast welcomed guest speaker Damiano de Felice, Chief of External Affairs at CARB-X. This year's WAAW theme is “Educate. Advocate. Act now.” In alignment with this theme, Damiano spoke about his work to advance conversations with governments around policies and actions needed to address AMR. Damiano shares his insights from Italy's recent investments in AMR and his ideas on how Canada can prepare for its upcoming G7 presidency to enhance countries' commitments to AMR.
In this thirteenth episode of the AMR Action Podcast, Dani Peters, CAIC Senior Advisor, speaks with Canadian Senator Mohamed-Iqbal Ravalia. Senator Ravalia reflects on his years of practicing and teaching medicine in Newfoundland and Labrador and the importance of a collaborative multidisciplinary approach to addressing the issue of antimicrobial resistance and antimicrobial stewardship. He also shares his insights as a parliamentarian on how the federal, provincial and territorial governments are working together on the implementation of the Pan-Canadian Action Plan on AMR, and shares some of Newfoundland's successes in addressing AMR at the local level.
In recognition of World AMR Awareness Week (WAAW), Steffanie Strathdee, Associate Dean of Global Health Sciences and Harold Simon Distinguished Professor in the Department of Medicine at the University of California San Diego School of Medicine, joined the AMR Action Podcast to share the story of how her husband's case of “Iraqibacter” led her to find a phage therapy that saved his life. Steffanie also shares her thoughts on opportunities for Canada to lead on AMR innovation, and the resources and regulations required to make phage therapy available as an alternative to antimicrobials in health settings across the United States, Canada and the world.Read Steffanie's book: The Perfect Predator: A Scientist's Race to Save Her Husband from a Deadly Superbug: A MemoirLearn more about Phage Canada.
Our eleventh AMR Action Podcast features an interview with Dr. Andrew Morris, Chair of the Expert Panel on Antimicrobial Availability to discuss the Council of Canadian Academies report, Overcoming Resistance. The report, commissioned by the Public Health Agency of Canada, describes the pull incentives that could help boost the availability of novel antimicrobials in Canada. The report was released on September 7, 2023.Dr. Morris is the Medical Director of the Antimicrobial Stewardship Program Sinai Health/University Health Network and Professor, Department of Medicine Faculty of Medicine at the University of Toronto.
In this tenth episode of the AMR Action Podcast, Dani Peters, CAIC Senior Advisor, speaks with Dr. Curtis Nickel, Professor Emeritus, Department of Urology, Queen's University and Kingston Health Sciences Centre, on the issue of urinary tract infections (UTIs), and why recurring UTIs present a public health issue, especially within the context of rising rates of antimicrobial resistance (AMR).Learn more about Dr. Curtis: https://urology.queensu.ca/faculty/j-curtis-nickel
Dr. Henry Skinner, CEO of the AMR Action Fund, joins Dani Peters, CAIC Senior Advisor, for World Antimicrobial Awareness Week to discuss the status of the global campaign to combat antimicrobial resistance in this 8th episode of the AMR Action Podcast. Dr. Skinner shares his perspective on the challenges with the broken market, and the barriers that need to be overcome in order to expedite innovation for new antimicrobials. He also discusses incentive models for policy makers and why more robust investments are needed from the private sector. Finally, he shares his optimism stemming from new technologies that are being tested and supported through the AMR Action Fund.
In this tenth episode of the AMR Action Podcast, Dani Peters, CAIC Senior Advisor, speaks with Dr. Sue Twine, National Research Council of Canada's Director General of the Human Health Therapeutics Research Centre, and researchers Dr. Danielle Peters and Alyssa McAdorey, about their work to address the growing public health threat of antimicrobial resistance and the importance of collaborating across institutions and industry in order to tackle the “next big silent pandemic.”
Our seventh episode of the AMR Action Podcast features Dr. Larissa Matukas, an Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto, Head of the Division of Microbiology and an Infectious Disease Consultant at St. Michael's Hospital, Unity Health Toronto. Dr. Matukas speaks about stewardship, surveillance and the use of diagnostic technologies to help combat antimicrobial resistance.
In this episode of the AMR Action Podcast, Lorna McEwan, a cystic fibrosis patient advocate spoke with Dani Peters, CAIC Senior Advisor, about her unique experiences as the oldest CF patient diagnosed at birth in Saskatchewan and her work as a CF advocate. Lorna shares her perspective regarding the importance of biomedical innovation, specifically how a gene-altering drug brought to Canada in 2021 has changed her life for the better. She also provides advice on how patients can advocate for themselves, not give up and share their experiences to impact broader policy and health care in Canada.
Patient advocates Hailey Laxer, cystic fibrosis (CF) patient, and Kristine Russell, sepsis survivor, speak with CAIC senior advisor Dani Peters about their unique patient journeys and how antibiotics have saved each of their lives. They discuss how the new antibiotic pipeline has dried up and the critical role of biomedical innovation in enabling Canadians to live healthier, better lives. Hailey and Kristine also share their personal stories and perspectives on how patients should be engaged in the issues related to antimicrobial resistance and access to newer antimicrobials in Canada.
Our fourth episode of the AMR Action Podcast features professors Dr. Lori Burrows, Associate Director of the Michael G. DeGroote Institute for Infectious Disease Research (IIDR), McMaster University, and Dr. Gerry Wright, Director of the IIDR, McMaster University. CAIC Senior Advisor Dani Peters speaks with Dr. Burrows and Dr. Wright about the McMaster Antibiotic Access & Capacity (MAAC) Project, a collaboration between CAIC and McMaster University. Steered by a committee whose members represent the many facets of the antibiotic space in Canada — industry, academia, economics, microbiology, policy, knowledge translation, and medicine — the MAAC Project was established to improve the health of Canadians by increasing prescribing options and optimizing the use of appropriate antibiotics via an integrated model that follows the principles of accessibility, stewardship, and reasonable costs. Tune in to the episode to learn more and access the full report: https://iidr.mcmaster.ca/MAAC/
Dans le troisième épisode du Podcast d'action sur la RAM, l'animatrice invitée Julie Barré s'entretient avec le Dr Daniel Thirion, Professeur titulaire de clinique à la Faculté de pharmacie de l'Université de Montréal, qui présente une perspective du Québec sur les innovations antimicrobiennes, la gérance des antimicrobiens et les raisons pour lesquelles combattre la résistance aux antimicrobiens est essentiel pour améliorer les résultats des patients.Julie Barré est une consultante sénior qui compte 25 années d'expérience professionnelle, dont 15 de celles-ci qui furent dédiée à la conceptualisation et la mise en place d'initiatives visant à transformer et améliorer les soins de santé pour la population canadienne.
Our second episode of the AMR Action Podcast features Dr. George Zhanel, Professor, Medical Microbiology/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, and Dr. Daniel Thirion, Professor and Pharmacist, Universite de Montreal and Royal Victoria Hospital. CAIC Senior Advisor Dani Peters speaks with Dr. Zhanel and Dr. Thirion about a range of topics, including the role of federal and provincial antimicrobial resistance (AMR) programs, the challenges associated with improving patient outcomes amidst growing AMR and the need to fix the broken market for new or newer antimicrobials in Canada.
Kevin Outterson, Professor of Law at Boston University, discusses incentive models for new antimicrobials and Canada's position internationally in the first episode of the AMR Action Podcast. Host: Dani Peters, Senior Advisor, Canadian Antimicrobial Innovation Coalition (CAIC).
© 2020-2025 Ivy Podcast Discovery LLC
